AACR Annual Meeting 2026

April 17–22, 2026 · San Diego · 2418 items

← Platform layer: molecular glues, spatial omics, AI

AMX-883

2 people · 2 posts

Heat trend for this story

Heat now 0·Peak in the comparable set 1 (Apr 21 02:00)·Change over 24h in the comparable set –·Participants now 1

Participants counted1

Heat over time

Participants counted above, heat below. The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's reading; the left and right arrow keys work too.

New Drugs on the Horizon put AMX-883 in a first-disclosure seat.

Records

Drug / trial	Readout	Setting
AMX-883AMX-883	BRD9 glue; structure and profile first disclosed	New Drugs on the Horizon

Other cases in this chapter

TLS AIDetection AUC 0.92; TLS-high OS HR 0.76
X-Atlas / Pisces25.6M-cell foundation model
FHD-909 / MRT-55811 / MR-2088Epigenetic / ULK tool molecules on the floor

Floor

Apr 21Tue

Tuesday · 2 items

14:27
Amphista Therapeutics@AmphistaTheraScore6060
Yesterday, for the first time, we presented the discovery, characterisation and chemical structure of our lead Targeted Glue™ AMX-883 d...
Same topic AMX-883 · 2 peopleHeat 22 likes0 replies0 reposts
01:55
Ingo Hartung@HartungIngoScore6060
Martin Pass from Amphista Tx disclosing AMX-883, a DCAF16 hijacking oral “targeted glue” of BRD9 to induce differentiation of AML cells. ...
Same topic AMX-883 · 2 peopleHeat 00 likes0 replies0 reposts